Jeff Yass’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.4M | Buy |
17,702
+2,499
| +16% | +$212K | ﹤0.01% | 7324 |
|
|
2026
Q1 | $1.31M | Buy |
15,203
+10,868
| +251% | +$975K | ﹤0.01% | 7214 |
|
|
2025
Q4 | $378K | Sell |
4,335
-26,261
| -86% | -$1.99M | ﹤0.01% | 9420 |
|
|
2025
Q3 | $1.75M | Sell |
30,596
-15,463
| -34% | -$890K | ﹤0.01% | 6075 |
|
|
2025
Q2 | $2.72M | Buy |
46,059
+33,904
| +279% | +$2.19M | ﹤0.01% | 5152 |
|
|
2025
Q1 | $890K | Buy |
+12,155
| New | +$1M | ﹤0.01% | 7538 |
|
|
2024
Q3 | – | Sell |
-17,965
| Closed | -$1.27M | – | 12363 |
|
|
2024
Q2 | $1.23M | Sell |
17,965
-29,309
| -62% | -$1.75M | ﹤0.01% | 6090 |
|
|
2024
Q1 | $2.54M | Sell |
47,274
-109,444
| -70% | -$5.88M | ﹤0.01% | 4843 |
|
|
2023
Q4 | $8.35M | Sell |
156,718
-164,857
| -51% | -$8.03M | ﹤0.01% | 2889 |
|
|
2023
Q3 | $16M | Buy |
321,575
+317,993
| +8,878% | +$17.8M | ﹤0.01% | 2002 |
|
|
2023
Q2 | $213K | Buy |
+3,582
| New | +$204K | ﹤0.01% | 10149 |
|
|
2022
Q4 | – | Sell |
-24,088
| Closed | -$1.64M | – | 12870 |
|
|
2022
Q3 | $1.44M | Buy |
+24,088
| New | +$1.45M | ﹤0.01% | 5708 |
|
|
2022
Q2 | – | Sell |
-2,936
| Closed | -$193K | – | 13267 |
|
|
2022
Q1 | $217K | Buy |
+2,936
| New | +$204K | ﹤0.01% | 11041 |
|
|
2021
Q2 | – | Sell |
-6,004
| Closed | -$427K | – | 12804 |
|
|
2021
Q1 | $370K | Sell |
6,004
-1,477
| -20% | -$93.5K | ﹤0.01% | 10155 |
|
|
2020
Q4 | $488K | Sell |
7,481
-29,078
| -80% | -$1.67M | ﹤0.01% | 8344 |
|
|
2020
Q3 | $1.81M | Sell |
36,559
-35,594
| -49% | -$1.84M | ﹤0.01% | 4814 |
|
|
2020
Q2 | $3.44M | Buy |
72,153
+25,683
| +55% | +$1.24M | ﹤0.01% | 3575 |
|
|
2020
Q1 | $1.98M | Buy |
46,470
+39,337
| +551% | +$1.94M | ﹤0.01% | 3984 |
|
|
2019
Q4 | $420K | Sell |
7,133
-51,714
| -88% | -$2.81M | ﹤0.01% | 7320 |
|
|
2019
Q3 | $3.01M | Buy |
58,847
+32,471
| +123% | +$1.55M | ﹤0.01% | 3485 |
|
|
2019
Q2 | $1.12M | Buy |
+26,376
| New | +$1.15M | ﹤0.01% | 5400 |
|
|
2017
Q4 | – | Sell |
-45,091
| Closed | -$1.58M | – | 9477 |
|
|
2017
Q3 | $1.34M | Buy |
45,091
+3,221
| +8% | +$98.3K | ﹤0.01% | 4699 |
|
|
2017
Q2 | $1.39M | Buy |
41,870
+32,621
| +353% | +$1.02M | ﹤0.01% | 4587 |
|
|
2017
Q1 | $274K | Buy |
+9,249
| New | +$252K | ﹤0.01% | 7487 |
|
|
2016
Q4 | – | Sell |
-9,931
| Closed | -$226K | – | 9773 |
|
|
2016
Q3 | $224K | Sell |
9,931
-77,248
| -89% | -$1.82M | ﹤0.01% | 7401 |
|
|
2016
Q2 | $2.08M | Buy |
87,179
+41,114
| +89% | +$986K | ﹤0.01% | 3507 |
|
|
2016
Q1 | $1.09M | Sell |
46,065
-12,703
| -22% | -$311K | ﹤0.01% | 4903 |
|
|
2015
Q4 | $1.64M | Sell |
58,768
-112,500
| -66% | -$2.82M | ﹤0.01% | 4447 |
|
|
2015
Q3 | $3.54M | Sell |
171,268
-7,984
| -4% | -$202K | ﹤0.01% | 3207 |
|
|
2015
Q2 | $4.6M | Buy |
179,252
+7,164
| +4% | +$181K | ﹤0.01% | 3050 |
|
|
2015
Q1 | $4.34M | Buy |
172,088
+17,129
| +11% | +$417K | ﹤0.01% | 2946 |
|
|
2014
Q4 | $3.68M | Buy |
154,959
+142,611
| +1,155% | +$3.16M | ﹤0.01% | 3361 |
|
|
2014
Q3 | $243K | Sell |
12,348
-37,599
| -75% | -$774K | ﹤0.01% | 8333 |
|
|
2014
Q2 | $1.2M | Buy |
49,947
+20,832
| +72% | +$503K | ﹤0.01% | 5669 |
|
|
2014
Q1 | $774K | Buy |
29,115
+15,071
| +107% | +$358K | ﹤0.01% | 5975 |
|
|
2013
Q4 | $283K | Buy |
+14,044
| New | +$261K | ﹤0.01% | 7674 |
|
Other funds holding GMED
JT
SC
Jeff Yass's GMED Position: Q2 2026 in Review
Jeff Yass increased its Globus Medical (GMED) stake by 16% in Q2 2026, buying an estimated $212K and bringing the position to 17,702 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #7324.
Jeff Yass first reported a position in GMED in Q4 2013 and has held it in 36 quarters since. The position peaked at $16M in Q3 2023. 594 funds tracked by Wall St. Rank hold GMED as of Q2 2026.
- Jeff Yass held 17,702 shares of Globus Medical worth $1.4M as of Q2 2026.
- Jeff Yass bought 2,499 Globus Medical shares in Q2 2026, an estimated $212K.
- Globus Medical made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #7324 holding.
- Jeff Yass first reported a position in Globus Medical in Q4 2013 and has held it in 36 quarters since.
- Jeff Yass's Globus Medical position peaked at $16M in Q3 2023.
- 594 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.